{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Altay raises $37 million for muscular dystrophy drug development","author_name":"techandbusiness.org · Startups","thumbnail_url":"https://s.yimg.com/lo/mysterio/api/15cc4764e11e3ccd4c8c3127a222536aa4e2bae13a74a861beb5ae6c20605651/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fbusiness-wire.com%2F8f05bfb31bd718800412438fc28c606b.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Startups</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/08sB0MH1dC_sdRGZY_14QF\" style=\"color:#fff;text-decoration:none;\">Altay raises $37 million for muscular dystrophy drug development</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Altay Therapeutics announced a $37 million Series A financing co-led by Sound Bioventures and HealthCap. The company plans to use the proceeds to advance DX5057 through Phase 1 and Phase 2 proof-of-co...</p>\n    </blockquote>"}